The challenges on developing vaccine against visceral leishmaniasis

The challenges on developing vaccine against visceral leishmaniasis

Bibliographic Details
Main Authors:	Selma Maria Bezerra Jerônimo, Richard D. Pearson
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT)
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000400395&lng=en&tlng=en

Similar Items

Development of Vaccines against Visceral Leishmaniasis
by: Krystal J. Evans, et al.
Published: (2012-01-01)

Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis
by: Mariana Costa Duarte, et al.

Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis
by: Javier Moreno
Published: (2019-06-01)

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
by: Malcolm S. Duthie, et al.
Published: (2017-08-01)

Canines vaccinated against visceral leishmaniasis develop a serological response to the Leishmania braziliensis antigen
by: Julia de Assis Pinheiro, et al.
Published: (2018-03-01)

Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
by: Lourena Emanuele Costa, et al.
Published: (2014-01-01)

Generation and evaluation of SMT-expressing «Lactococcus lactis» live vaccines against visceral leishmaniasis
by: Mahbuba, Raya
Published: (2011)

Changing demographics of visceral leishmaniasis in northeast Brazil: Lessons for the future.
by: Iraci Duarte Lima, et al.
Published: (2018-03-01)

Visceral Leishmaniasis: Advancements in vaccine development via classical and molecular approaches
by: Sumit eJoshi, et al.
Published: (2014-08-01)

Miltefosine: great expectations against visceral leishmaniasis.
by: More B, et al.
Published: (2003-01-01)

Visceral leishmaniasis in large Brazilian cities: challenges for control
by: Claudia Di Lorenzo Oliveira, et al.
Published: (2008-12-01)

Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.
by: Pramod K Kushawaha, et al.
Published: (2012-01-01)

Dual immune modulatory effect of vitamin A in human visceral leishmaniasis.
by: Bruna L Lima Maciel, et al.
Published: (2014-01-01)

Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis
by: Rory Cristiane Fortes De Brito, et al.
Published: (2020-05-01)

Challenges in visceral leishmaniasis control and elimination in the developing countries: A review
by: Tadesse Hailu, et al.
Published: (2016-01-01)

Development and evaluation of macrophage targeted multidrug therapy against visceral leishmaniasis
by: Prachi sharma, et al.
Published: (2017-05-01)

Can vaccines against canine visceral leishmaniasis interfere with the serological diagnostics recommended by the Brazilian Ministry of Health?
by: Monique Paiva de Campos, et al.

Visceral leishmaniasis: a challenging diagnosis in internal medicine
by: M. Iu. Brovko, et al.
Published: (2020-12-01)

The potential impact of human visceral leishmaniasis vaccines on population incidence.
by: Epke A Le Rutte, et al.
Published: (2020-07-01)

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
by: Dinesh Mondal, et al.
Published: (2019-10-01)

Exploring sand fly salivary proteins to design multiepitope subunit vaccine to fight against visceral leishmaniasis
by: R. Pandey, et al.
Published: (2020-12-01)

Visceral leishmaniasis in Brazil: trends and challenges Leishmaniose visceral no Brasil: evolução e desafios
by: Ana Nilce Silveira Maia-Elkhoury, et al.
Published: (2008-12-01)

Determinants for the development of visceral leishmaniasis disease.
by: Laura-Isobel McCall, et al.
Published: (2013-01-01)

Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study
by: João Victor Soares Coriolano Coutinho, et al.

Leishmaniasis visceral canina
by: Bruno L. Trav
Published: (2000-01-01)

Epidemiology of visceral leishmaniasis
by: Ready PD
Published: (2014-05-01)

Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01)

Immunobiology of visceral leishmaniasis
by: Susanne eNylén, et al.
Published: (2012-08-01)

Congenital Visceral Leishmaniasis
by: Catharina C. Boehme, et al.
Published: (2006-02-01)

Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01)

Designing of epitope based vaccine for visceral leishmaniasis: A bioinformatics study
by: P. Slathia, et al.
Published: (2020-12-01)

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
by: Subir Karmakar, et al.
Published: (2021-07-01)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
by: Om Prakash Singh, et al.
Published: (2015-01-01)

Comorbid infections induce progression of visceral leishmaniasis
by: Angela J. Toepp, et al.
Published: (2019-01-01)

Visceral leishmaniasis diagnosed by duodenal biopsy Leishmaniasis visceral diagnosticada por biopsia duodenal
by: L. del Olmo Martínez, et al.
Published: (2009-06-01)

Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, london.
by: Kate Fletcher, et al.
Published: (2015-01-01)

Visceral leishmaniasis research: operational focus needed
by: Richard Reithinger
Published: (2015-04-01)

Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
by: Pramod Kumar Kushawaha, et al.
Published: (2012-01-01)